CoChat

Effects of peroral and transdermal oestrogen replacement therapy on glucose and insulin metabolism

Karjalainen, A., Paassilta, M., Heikkinen, J., Bäckström, A‐C., Savolainen, M., Kesäniemi, Y. A. · 2001 · Clinical Endocrinology
Cited by 44

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

OBJECTIVE: Conflicting data have been reported previously on the effects of oestrogen replacement therapy on glucose tolerance, and the effects on glycosylated haemoglobin GHbA 1c have been studied only among diabetics. The objective of this studywas to evaluate the effects on glucose and insulin metabolism among nondiabetic women and to compare the outcomes of peroral and transdermal modes of administration. DESIGN: The effects of peroral oestradiol valerate 2 mg/day with placebo gel were compared to those of transdermal 17β‐oestradiol gel (1 mg oestradiol/day) and placebo tablets in a randomised, double‐blind, double‐dummy study for six months. PATIENTS: Seventy‐nine hysterectomised, nondiabetic postmenopausal women, 39 women in the peroral oestrogen group and 40 in the gel group. MEASUREMENTS: Oral glucose tolerance tests (OGTT) with blood glucose, serum C‐peptide and insulin determinations were performed. GHbA 1c, IGF‐I and IGFBP‐1 were measured at baseline and after six months of therapy. In addition, insulin sensitivity and insulin secretion indices were obtained from OGTT. RESULTS: A small significant reduction in the GHbA 1c concentration was observed during both peroral (P < 0·05) and transdermal oestrogen therapy (P < 0·05). However, no effect on insulin sensitivity was observed. The response to a standard 75 g oral glucose load was similar in the study groups. Compared with the baseline values, the area under the curve for C‐peptide decreased by 8% both in the peroral group (P < 0·05) and in the gel group (P < 0·01). The fasting and postchallenge glucose and insulin levels or insulin release indices were not significantly altered. Peroral oestrogen decreased IGF‐I and increased IGFBP‐1, but these findings were not associated with the changes in glucose metabolism. CONCLUSIONS: Neither peroral nor transdermal oestradiol replacement therapy seemed to induce any negative effects on glucose metabolism over a time period of 6 months.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1046/j.1365-2265.2001.01208.x

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 44

Metadata

Authors
Karjalainen, A., Paassilta, M., Heikkinen, J., Bäckström, A., Savolainen, M., & Kesäniemi, Y. A.
Venue
Clinical Endocrinology
Publisher
Wiley
Published
2001-02
Volume
54
Issue
2
Pages
165-173
ISSN
  • 0300-0664 (ISSN-L)
  • 1365-2265
OpenAlex
W2147979501
Cited by
44
References
4
FWCI
2.49
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effects of peroral and transdermal oestrogen replacement therapy on glucose and insulin metabolism. https://app.cochat.ai/papers/10.1046/j.1365-2265.2001.01208.x
The paper
Karjalainen, A., Paassilta, M., Heikkinen, J., Bäckström, A., Savolainen, M., & Kesäniemi, Y. A. (2001). Effects of peroral and transdermal oestrogen replacement therapy on glucose and insulin metabolism. Clinical Endocrinology. https://doi.org/10.1046/j.1365-2265.2001.01208.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.